-
A Conversation With Alexa D’Angelo, Ph.D., M.P.H., Recent Doctoral Graduate from the CUNY School of Public Health and Health Policy
23 Aug 2025 01:58 GMT
… P.H., a recent doctoral graduate from the CUNY … by PrEP drug.
For generic tenofovir disoproxil and emtricitabine (TDF … where negotiations between drug manufacturers and pharmaceutical benefits managers result … health insurance and through Medicaid plans in both …
-
Gilead Sciences’ Biktarvy granted FDA approval for expanded HIV use
18 Aug 2025 12:25 GMT
… Sciences’ Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg … complete HIV treatment that combines three medicines in a single pill and reduces … pre-exposure prophylaxis (PrEP) drug received FDA approval to prevent HIV.
Yeztugo …
-
Intermittent Antiretroviral Therapy Can Work as Well as Daily Treatment
13 Aug 2025 20:44 GMT
… controlled trials comparing intermittent three-drug regimens versus daily treatment. … 47;tenofovir alafenamide/emtricitabine) and one evaluated various … Baylor College of Medicine Children’s Foundation- … and continuous treatment took 92% of their pills. “ …
-
Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
07 Aug 2025 20:05 GMT
… Short Treatment Duration, Low Risk for Drug-Drug Interactions … (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) … patients take multiple medications to manage comorbidities … HIV) regimen bictegravir/emtricitabine/tenofovir alafenamide (B …
-
FDA Approves Biktarvy for Patients With HIV Previously Treated With Antiretroviral Therapy
06 Aug 2025 19:24 GMT
… evidence from 2 phase 3 trials: study 1489 (NCT02607930) and study … for our free Drug Topics newsletter.
REFERENCES
1. US FDA approves new … . Bictegravir/emtricitabine/tenofovir alafenamide as initial treatment for HIV-1 …
-
Biktarvy Granted New Indication for HIV Treatment
06 Aug 2025 05:53 GMT
… the Food and Drug Administration (FDA) approved a new … resistance to the drugs in the combination pill. Biktarvy, … alafenamide (TAF) and emtricitabine.
“This expanded indication can … to restart treatment without viral suppression. Clinical trials of …
-
Promising new monthly pill moves to phase-three trials in HIV prevention revolution
02 Aug 2025 20:32 GMT
… The daily pill contains the antiretroviral drugs tenofovir disoproxil fumarate and emtricitabine.
Latest … , a professor of medicine at Harvard Medical School, who presented … -three trials
Merck, the pharmaceutical company that’s developing the pill, announced …
-
Gilead Sciences gets USFDA nod for new Biktarvy indication for people with HIV who are treatment experienced, restarting antiretroviral treatment
02 Aug 2025 08:57 GMT
… ) class, emtricitabine or tenofovir. The approval of this supplemental New Drug Application … given the limited treatment options approved by the FDA for this population … suppressed and are restarting HIV treatment.”
FDA granted this new indication based …
-
Ulonivirine Shows Promise for Weekly Oral HIV Treatment
30 Jul 2025 22:26 GMT
… trouble taking a pill every day. Oral medications that can … too high, and some treatment trials later resumed using a … #47;tenofovir alafenamide/emtricitabine) with viral suppression for at … Biktarvy recipients to experience drug-related adverse events (17 …
-
Lenacapavir PrEP ‘special cases’: young people, missed doses and drug interactions
30 Jul 2025 16:00 GMT
… PrEP tablets (emtricitabine plus either tenofovir … drug resistance mutation to lenacapavir. While lenacapavir is rarely used for treatment … pill per week until injections can be resumed. If, however, the pills … usual.
Two statins, lovastatin and simvastatin …
About
© 1995-2025